Interferon alpha in the treatment of AIDS-related Kaposi's sarcoma (Q37422340)

20 August 2017

1 reference

title

Interferon alpha in the treatment of AIDS-related Kaposi's sarcoma (English)

1 reference

20 August 2017

0 references

Mitsuyasu RT

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 October 1991

1 reference

British Journal of Haematology

20 August 2017

published in

1 reference

20 August 2017

volume

79 Suppl 1

1 reference

20 August 2017

page(s)

69-73

1 reference

Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08124.X

AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08124.X

Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08124.X

Recombinant human interferon alfa-A suppresses HTLV-III replication in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08124.X

Three-drug synergistic inhibition of HIV-1 replication in vitro by zidovudine, recombinant soluble CD4, and recombinant interferon-alpha A

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08124.X

Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08124.X

Type I interferons (alpha and beta) in HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08124.X

Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08124.X

Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08124.X

Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi sarcoma. A phase II randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08124.X

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08124.X

AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08124.X

Heterogeneity of epidemic Kaposi's sarcoma. Implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08124.X

Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08124.X

Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08124.X

Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08124.X

Outbreak of Kaposi's sarcoma with cytomegalovirus infection in young homosexual men

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08124.X

Synergistic interaction of 2',3'-dideoxycytidine and recombinant interferon-alpha-A on replication of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08124.X

The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08124.X

10.1111/J.1365-2141.1991.TB08124.X

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference